title: A case of 43-year-old fighter pilot with bronchial asthma.
abstract: A Japan Air Self-Defense Force (JASDF) fighter pilot with adult onset atopic bronchial asthma was successfully returned to flying status. This was against the common wisdom of most Japanese military flight surgeons. Bronchial asthma generally results in permanent disqualification from flying duties because of possible acute incapacitation during flight. This JASDF pilot was treated with inhaled medications, including beclomethasone, for 6 mo with suppression of all clinical symptoms. All medications were discontinued and the pilot was observed for another 7 mo before resumption of flying status. This aeromedical disposition was based on the thinking that his long asymptomatic period indicated bronchial inflammation was resolved, bronchial reactivity was improved, and thus the risk of exacerbation was reduced.
authors.affiliation: Japan Air Self-Defense Force Aeromedical Laboratory, Tachikawa AB, Tokyo.
authors.forename: O
authors.initials: O
authors.lastname: Tokumaru
authors.forename: I
authors.initials: I
authors.lastname: Yoneda
authors.forename: A
authors.initials: A
authors.lastname: Takeuchi
authors.forename: K
authors.initials: K
authors.lastname: Ohashi
authors.forename: M
authors.initials: M
authors.lastname: Kido
authors.forename: A
authors.initials: A
authors.lastname: Nakamura
mesh_terms: D000328:Adult; D018927:Anti-Asthmatic Agents / Q000627:therapeutic use*; D000893:Anti-Inflammatory Agents / Q000627:therapeutic use*; D001249:Asthma / Q000175:diagnosis / Q000188:drug therapy* / Q000209:etiology; D001507:Beclomethasone / Q000627:therapeutic use*; D004185:Disability Evaluation; D006801:Humans; D007564:Japan; D008889:Military Personnel; D010366:Peak Expiratory Flow Rate / Q000187:drug effects
chemical_list: D018927:Anti-Asthmatic Agents; D000893:Anti-Inflammatory Agents; D001507:Beclomethasone